Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cinryze
Cinryze
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Fierce Pharma
Wed, 08/25/21 - 09:32 pm
Takeda
CSL
hereditary angiodema
HAE
RWE
Takhzyro
Cinryze
Haegarda
Cost-effectiveness doubts could hit Shire’s Takhzyro launch
EP Vantage
Fri, 10/12/18 - 11:43 pm
Shire
Cinryze
Takhzyro
drug pricing
hereditary angiodema
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Fierce Pharma
Thu, 06/21/18 - 12:02 pm
CSL
HAE
Shire
Cinryze
Haegarda
Shire set for in-house production of rare disease drug Cinryze after shortage issues
Fierce Pharma
Thu, 01/25/18 - 12:00 am
Shire
Cinryze
drug shortages
HAE
drug manufacturing
Shire’s multibillion-dollar gamble on lanadelumab pays off with stellar PhIII data, quick marketing application
Endpoints
Thu, 05/18/17 - 09:38 am
Shire
lanadelumab
DX-2930
HAE
Cinryze
Dyax
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb
Dyax's Threat to $630,000 Shire Drug Makes It a Target
Bloomberg
Thu, 06/11/15 - 10:13 am
Shire
Dyax
DX-2930
HAE
hereditary angiodema
Cinryze
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
An Interesting Bio Play in the Blood Disorder Niche
Motley Fool
Tue, 07/2/13 - 01:39 am
hereditary angiodema
Dyax
Shire
CSL
ViroPharma
Biovitrum
Halozyme
Cinryze
Spec Stock: Cramer Profiles an Orphan Drug Maker (video)
CNBC
Sat, 03/9/13 - 11:50 am
Cinryze
hereditary angiodema
ViroPharma
orphan drugs
ViroPharma up, FDA lifts ban
Yahoo/Investor's Business Daily
Sat, 09/22/12 - 02:22 pm
Cinryze
angioedema
ViroPharma, Halozyme Rise After FDA Issue Cleared Up
Investors.com
Fri, 09/21/12 - 01:11 pm
Halozyme
FDA
ViroPharma
Cinryze
hereditary angiodema
Dyax And ViroPharma: An Overview Of HAE Space
Seeking Alpha
Wed, 09/19/12 - 10:58 am
ViroPharma
Dyax
Cinryze
hereditary angiodema
Kalbitor
Bad News for ViroPharma
Yahoo/Zacks
Sat, 08/4/12 - 11:20 am
ViroPharma
Halozyme
Cinryze
rHuPH20
Are Supply Troubles a Biotech Buying Opportunity?
Motley Fool
Sat, 05/5/12 - 12:36 pm
ViroPharma
Cinryze
ViroPharma's HAE Drug Gets EU Nod
Yahoo/Zacks.com
Thu, 06/16/11 - 11:29 am
hereditary angiodema
ViroPharma
Europe
Cinryze
Halozyme
ViroPharma Inks Deal with Halozyme
Yahoo/Zacks
Sat, 05/14/11 - 12:31 pm
ViroPharma
Halozyme
rHuPH20
Cinryze
hereditary angiodema
angioedema
ViroPharma Gives It a Shot
Motley Fool
Fri, 05/13/11 - 10:45 am
ViroPharma
Cinryze
hereditary angiodema
ViroPharma hopes deal will bring subcutaneous form of Cinryze
Bizjournals.com
Wed, 05/11/11 - 12:33 pm
ViroPharma
Cinryze
Halozyme
hereditary angiodema
ViroPharma Drug Nears EU Approval
Investor's Business Daily
Sat, 04/2/11 - 10:19 am
ViroPharma
angioedema
Cinryze
Pages
1
2
next ›
last »